BioSpace News Archive

Dyne Therapeutics, a biotechnology company pioneering life-transforming therapies for patients with serious muscle diseases, today announced the appointment of Daniel Wilson as vice president, head of intellectual property

SkinScience Labs, Creator of Award-Winning Dr. Denese Skin Care & Anti-Aging Product Lines, Enters Hand Sanitizer Market with Proprietary Formula Developed by Founder Adrienne Denese, MD., Ph.D.

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company has filed patent applications for a point-of-care device which improves the speed and accuracy of lateral flow immunoassays (LFIA) to detect COVID-19

Emergent will provide contract development and manufacturing services and secure large-scale manufacturing capacity through 2020 to support AstraZeneca’s COVID-19 vaccine candidate Agreement valued at approximately $87 million GAITHERSBURG, Md., June 11, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced it will deploy its molecule-to-market contract development and manufacturing (CDMO) services to support the manufacturing of AstraZeneca’s vaccine candidate for

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced that the Medicines and Healthcare products Regulatory Agency (MHRA; the UK equivalent of the FDA) has given approval to i

Regence today announced a new partnership with Healthmap Solutions—a growing national Population Health Management company with a flagship Kidney Health Management (KHM) program—to improve care and outcomes for Regence members with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD).

Next Generation Closed Loop Insulin Pump System Features Auto-Correction Algorithm and Bluetooth Connectivity

Applying Prosaro® fungicide at early flowering helps protect grain quality, yield and profitability in cereal crops

Bold Therapeutics, a clinical-stage biopharmaceutical company, has expanded its COVID-19 collaborations to include four more academic researchers: Francois Jean , PhD and Ted Steiner , MD, both researchers from the University of British Columbia ; Stephen Barr , PhD, a researcher at Western University ; and Len Seymour , PhD, a r

EpicGenetics to offer a no-fee immune system COVID-19 FDA-authorized antibody test with every FM/a® Test